MSH|^~\&|LAB|ARH|||201911151425||ORU^R01|4106562|D|2.3|||AL|NE
PID|1||AB00008352|AB8265|LABTEST^FARM^FARE||19770415|M||||||||||AB000667/19|9874872044
OBR|1|35219^LAB|00027056^1511:C00006R^LAB^151119:C6^35219|220.5080^HFE CD^Hemochromatosis-Conf Diagnosis^^^XXX-1182||201911151424|201911151423|||||||201911151423||||||||||LAB|I||||
OBR|2|35219^LAB|00027056^1511:C00006R^LAB^151119:C6^35219|520.4200^IRON^Iron Studies Profile^^^50190-8||201911151424|201911151423|||||||201911151423||||||||||LAB|F||||
OBX|1|ST|520.4300^FE^Iron^^14798-3^14798-3|1|22^^Y|umol/L|9-30|N||A^S|F|||201911151425
OBX|2|ST|520.4500^TIBC^Total Iron Binding Capacity^^14800-7^14800-7|1|44^^Y|umol/L|45-70|L||A^S|F|||201911151425
OBX|3|ST|520.4600^TRFSAT^Transferrin Saturation^^6796-7^14801-5|1|0.50^^Y||0.15-0.55|N||A^S|F|||201911151425
NTE|1||High transferrin saturation, suggest repeat for confirmation
NTE|2||and if it remains >0.45, followup as per BCMA/MSP protocol
NTE|3||for Iron Overload.